Literature DB >> 30076088

Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series.

Alessandro Tomelleri1, Corrado Campochiaro2, Giacomo De Luca2, Giulio Cavalli2, Lorenzo Dagna2.   

Abstract

Entities:  

Keywords:  Immune checkpoint inhibitors; Leucocytoclastic vasculitis; Lung cancer; Vasculitis

Mesh：

Substances：

Year:  2018        PMID： 30076088     DOI： 10.1016/j.ejim.2018.07.023

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN： 0953-6205            Impact factor:   4.487


× No keyword cloud information.
  8 in total

Review 1.  A Spotlight on Drug-Induced Vasculitis.

Authors:  Kinanah Yaseen; Alana Nevares; Hiromichi Tamaki
Journal:  Curr Rheumatol Rep       Date:  2022-09-21       Impact factor: 4.686

Review 2.  Diagnosis and management of leukocytoclastic vasculitis.

Authors:  Paolo Fraticelli; Devis Benfaremo; Armando Gabrielli
Journal:  Intern Emerg Med       Date:  2021-03-13       Impact factor: 3.397

Review 3.  Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors.

Authors:  Konstantinos Melissaropoulos; Kalliopi Klavdianou; Alexandra Filippopoulou; Fotini Kalofonou; Haralabos Kalofonos; Dimitrios Daoussis
Journal:  Int J Mol Sci       Date:  2020-05-11       Impact factor: 5.923

4.  Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy.

Authors:  Marie Kostine; Marie-Elise Truchetet; Thierry Schaeverbeke
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

5.  A Case of IgA Vasculitis During Nivolumab Therapy for Renal Cell Carcinoma.

Authors:  Asami Nagaoka-Takatori; Madoka Ishii; Koremasa Hayama; Daisuke Obinata; Kenya Yamaguchi; Satoru Takahashi; Hideki Fujita
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-12-24

Review 6.  Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management.

Authors:  Zoe Apalla; Bernardo Rapoport; Vincent Sibaud
Journal:  Int J Womens Dermatol       Date:  2021-10-23

7.  Nivolumab associated vasculopathy: A novel mechanism.

Authors:  Adeeb Haroon; James K Parker; Kara Braudis; Emily H Smith
Journal:  JAAD Case Rep       Date:  2022-01-29

8.  A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim.

Authors:  Joseph Mort; Shipra Maheshwari; Nayanika Basu; Patrick Dillon; Kevin Brady; Harry Bear; Trish Millard
Journal:  Case Rep Oncol Med       Date:  2022-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.